News

Photo
18.03.2021 • NewsInnovation

New Ammonia Synthesis Technology

Tsubame BHB was established in April of 2017 based on a new catalyst technology developed by Prof. em. Hideo Hosono at the ­Tokyo Institute of Technology (Tokyo Tech), which allows an ammonia process at lower temperature and pressure.

Photo
17.03.2021 • News

CO2-Neutral Chemical Industry

The European Chemical Industry has set out on an ambitious path to become carbon neutral. Germany, as one of the major chemical manufacturing nations, has committed to achieve this goal by 2050.

Photo
17.03.2021 • News

Clariant and India Glycols Form Renewables JV

Clariant and India Glycols Limited (IGL) are forming a joint venture for renewable ethylene oxide (EO) derivatives. To support production, IGL has entered into long-term supply agreement for EO made from bio-ethanol as well as further utilities.

Photo
17.03.2021 • News

Thermo Fisher to Upgrade Bioprocessing Operations

Thermo Fisher Scientific plans to spend more than $600 million to upgrade its bioprocessing operations up to 2022. It aims to more than double current manufacturing capacity and support biopharma customers as they ramp up to meet short-term demands related to COVID-19. Another goal is to support its own long-term efforts to develop new vaccines and biologics for other conditions.

Photo
17.03.2021 • News

Not all Gloom for German Chemicals in 2020

Punctuated by lockdowns and gaps in raw materials supply, pandemic year 2020 presented major challenges for German chemical and pharmaceutical producers. However, due to a strong fourth quarter performance in which both sales and production rose against the third quarter, the industry association Verband der Chemischen Industre (VCI), said business was better than expected.

Photo
17.03.2021 • NewsLogistics

Tune Your Warehouse

The changes in customer needs and market requirements have not only been changing because of the pandemic influences within the last year, but traditional business models were quickly considered outdated in the current environment.

Photo
16.03.2021 • News

Ajinomoto in Talks with Metex on Animal Feed Unit

Japan’s Ajinomoto has entered into exclusive negotiations with French fermentation firm METabolic EXplorer to sell its entire stake in Ajinomoto Animal Nutrition Europe (AANE), based in Amiens, France. The company said the sale its part of a strategic reshaping of its portfolio and a restructuring of non-core businesses.

Photo
16.03.2021 • News

Saudi Ministry Approves Advanced Petrochemical Complex

Advanced Global Investment Company (AGIC), a subsidiary of Saudi Arabian PP producer Advanced Petrochemical, has received approval from the Ministry of Energy for the allocation of feedstock to supply its proposed petrochemical complex in Jubail Industrial City.

Photo
16.03.2021 • News

Germany Seeks Self Reliance in Vaccine Production

As one glitch after another at Covid vaccine suppliers upends deliveries, the German federal government is drawing up plans to build up production within its borders, federal health minister Jens Spahn said at a weekly news conference, thereby confirming remarks made by future vaccine commissioner Christoph Krupp in a pre-published newspaper interview.

Photo
15.03.2021 • News

Petronas Signs Abu Dhabi Collaborations

Malaysian state-owned oil and gas group Petronas has signed Memoranda of Understanding (MoU) with Abu Dhabi National Oil Company (ADNOC) and renewable energy company Masdar, both in the United Arab Emirates (UAE).

Photo
15.03.2021 • News

AstraZeneca-EU Relationship Sours Further

Astra Zeneca’s relationship with the EU is at rock bottom. Within three days, news emerged of deaths from blood clots in people receiving the UK drugmaker’s vaccine, and drugs regulator European Medicines Agency (EMA) said it was studying reports that 41 people receiving the shot in the UK had suffered an anaphylaxis reaction. What’s more, the company just took back another supply commitment.

Photo
15.03.2021 • News

EU Firms in Alliance for Green Hydrogen

Seven companies from the European GET H2 hydrogen initiative, including chemical producer Evonik, have established a consortium to help promote industrial offtake of climate-friendly green hydrogen from renewable energies.

Photo
13.03.2021 • NewsChemistry

Recycled and Carbon-neutral Precious Metals

Over the years, sustainability has evolved from an aspirational goal to an operational priority. Companies in every industry are being asked to incorporate more environmental stewardship into their operations and business practices.

Photo
13.03.2021 • NewsStrategy

Renewable Hydrogen

To take advantage of the opportunity hydrogen presents, the European chemical industry must engage in the emerging hydrogen market now, setting up specific pilots, develop an appropriate partner and ecosystem network and, most crucially, adapt the R&D portfolios and investment plans needed to capture a share of the hydrogen opportunity.

Photo
12.03.2021 • News

IMCD sells Nutri Granulations to Huber

IMCD has agreed to sell its Nutri Granulations business to Huber Engineered Materials, a division of J.M. Huber, for an undisclosed sum. The transaction is expected to close by Apr. 1. The Dutch distributor originally acquired the business as part of its takeover of US specialty chemicals distributor E.T. Horn in June 2018.

Photo
12.03.2021 • News

OMV Plans Glycerin-to-Propanol Pilot Plant

Austrian energy and chemicals company OMV has announced plans to invest about €30 million in a pilot plant that will produce propanol from glycerin. Construction is planned to start in the second quarter of 2021, with the plant due to go into operation in 2023.

Photo
12.03.2021 • News

Eight Countries Halt AstraZeneca Shot on Blood Clot Fears

AstraZeneca’s Covid vaccine is drawing negative headlines again after several incidences of blood clots have been reported, including the death of a 49-year-old nurse from multiple thrombosis 10 days after receiving the shot. On Mar. 10, eight countries had suspended injections from a batch labeled ABV5300 or halted use of this vaccine pending clarification.

Photo
12.03.2021 • News

EMA Clears J&J Covid Vaccine for Marketing

The EU cleared Johnson & Johnson’s Covid-19 vaccine for conditional marketing in all 27member states on Mar. 11 as expected. The single-dose adenovirus shot made by subsidiary Janssen Biotech, under a rolling review since December 2020, is the fourth to be approved by the European Medicines Agency (EMA).

Photo
11.03.2021 • News

Saipem Plans Green Hydrogen Projects

Italian engineering and construction firm Saipem has signed a Memorandum of Understanding (MoU) with compatriot company Alboran Hydrogen to jointly develop and build five plants for producing green hydrogen via electrolysis.

Photo
11.03.2021 • News

WuXi AppTec Buys British CDMO Oxgene

China’s WuXi AppTec has acquired British gene therapy CDMO Oxgene, making the Oxford-based company a wholly owned subsidiary of the contract testing, development and manufacturing business unit for cell and gene therapies, WuXi Advanced Therapies. With the sale, Oxgene will retain its name.

Photo
11.03.2021 • News

EU Orders 4 Million More Comirnaty Doses

Trying to stay ahead of both coronavirus developments and criticism that it is moving too slowly or in the wrong direction, Europe is piling on fresh orders for the BioNTech-Pfizer vaccine. On Mar. 10, it announced it had agreed to acquire 4 million additional doses for delivery in the next two weeks.

Photo
10.03.2021 • News

Amgen Boosts Oncology Portfolio with Five Prime Buy

Amgen is to buy Five Prime Therapeutics, a clinical-stage biotech focused on developing immuno-oncology and targeted cancer therapies, for about $1.9 billion. The transaction is expected to close by the end of the second quarter, when a wholly owned subsidiary of Amgen will merge with Five Prime.

Photo
10.03.2021 • News

Dow Plans China Specialties Hub

Dow has signed a Memorandum of Understanding (MoU) with the Zhanjiang Economic and Technological Development Zone Administrative Committee (Zhanjiang EDZ) to build the Dow South China Specialties Hub, a multi-year project providing customers local access to its products and technologies.

Photo
10.03.2021 • News

Russian Covid Vaccine to be Made in Italy

The Russian government has clinched a deal to produce its Sputnik V Covid-19 vaccine in Italy and will proceed with the project even if the European Medicines Agency (EMA) decides not to approve the candidate, the Italian-Russian Chamber of Commerce said. “The innovative production process will help create new jobs and allow Italy to control the entire production of the compound,” it added.

10960 more News

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.